Journal News

Democratizing calcium visualization

Laurel Oldach
Dec. 7, 2021

At a time when cloning a gene was a feat worthy of a high-impact publication, someone asked Roger Tsien why he studied calcium.

Tsien-Roger-300x341.jpg
Wikimedia Commons
Roger Tsien

“His somewhat flippant answer was, ‘Because it cannot be cloned,’” recalled Joseph Kao, who was a postdoc in Tsien’s lab and is now a professor at the University of Maryland. “Early on, he was actually somewhat dismissive of molecular biology.”

Tsien, who died in 2016, is best remembered for his contributions to developing a molecular biology icon: green fluorescent protein. His group’s work helped transform the protein from a coelenterine curiosity to a laboratory staple and earned Tsien a third of the 2008 Nobel Prize in chemistry. Prior to launching that project in the 1990s, Tsien already had revolutionized the field of calcium sensing.

In the 1970s, Kao said, measuring calcium was “a very rarefied, arcane art” that depended on a deep knowledge of electrophysiology. Today, researchers can use a variety of fluorescent indicators to visualize the activity of calcium and other second messengers in living cells. Many modern indicators derive from a series of probes that Tsien’s lab developed.

In one Journal of Biological Chemistry Classic article on such probes, “Ca2+ indicators based on fluoresceins and rhodamines,” Akwasi Minta, Kao and Tsien introduced several fluorescent indicators of Ca2+ concentration that could be used in cells.

Tsien began to pursue an interest in calcium signaling early in his scientific career. The ion already was known as an important signal carrier central to muscle contraction, synaptic transmission and many other physiological functions.

“Calcium was central to everything — but it was very difficult to measure,” Kao said. Tsien considered electrophysiology as an undergraduate, but by the time he started his graduate research at Cambridge, he was focused on chemical approaches.

The first Ca2+ chelator Tsien developed, 2-bis(o-aminophenoxy)ethane-N,N,N′,N′-tetraacetic acid, or BAPTA, remains widely used because of its rapid binding kinetics, high selectivity for calcium and insensitivity to pH changes in the physiological range. BAPTA binds calcium through four carboxylate groups.

Joseph Kao
Nonprotonated structures of BAPTA and Fluo3. When Ca2+ is present, the carboxylic acid groups coordinate the cation.

At the University of California, Berkeley, Tsien led a lab that developed the calcium probes fura-2 and indo-1, which are elaborations of the BAPTA architecture. Both of these molecules are intrinsically fluorescent, but upon binding Ca2+, the shapes of their fluorescence spectra change. The ratio of the fluorescence intensities at two different wavelengths can be calibrated into actual Ca2+ concentration. Because such ratiometric measurements are insensitive to the concentration of indicator in the sample, some common experimental artifacts are minimized. Still, Tsien was disappointed that they required long-wavelength ultraviolet excitation, which potentially can harm cells and excite autofluorescence. Tsien was initially reluctant to publish on the new indicators, Kao said, but ultimately yielded to persuasion by postdoc Martin Poenie.

Tsien was intent on developing a fluorescent Ca2+ indicator with excitation in the visible range. Perhaps it could be done by combining BAPTA with the visible fluorescence of already available fluorophores? He recruited postdocs Minta, a chemist, and Kao, a biophysicist, to work on the project.

First, the molecules had to be synthesized. An early synthetic strategy involved a long pressurized incubation in an aluminum instrument that resembled an old-fashioned coffee urn. Kao recalled a time when the chemists left a reaction to run over the weekend, hoping to improve its yield.

“When we came back … there was an imprint where the lid handle had smashed into the ceiling. Somewhere else, we found the lid completely flattened.” The reaction also had shattered an internal glass ampule, leaving glass dust all over the lab.

“Subsequently, they found better ways to do that reaction,” Kao said.

Even after the molecules were synthesized, the work was not complete. “Roger was a perfectionist,” Minta said. “If I did a dye and it had certain imperfections, he made me start all over again.”

Some molecules he generated failed to fluoresce or were protonated at near-physiological pH. Minta tweaked and adapted, adding and modifying functional groups until he had two chimeric molecules, derived from the fluorophores rhodamine and fluorescein, that were weakly fluorescent on their own but lit up dramatically when Ca2+ bound. The lab dubbed the probes fluo-3 and rhod-2.

Ordinarily, when a molecule absorbs light, the energy is dispersed quickly as molecular motion, or heat. Fluorescence — the release of captured light energy as a photon — requires special circumstances.

“When a molecule absorbs light, an electron is promoted from a lower-energy level into a higher-energy level, leaving a vacancy in the lower level,” Kao said. Emission of a photon depends on the excited electron returning to its normal lower-energy state. If an electron elsewhere in the molecule is free to slip into that lower orbital, he said, the excited electron’s energy ultimately is lost as heat instead of being emitted as light, a phenomenon known as fluorescence quenching.

Joseph Kao
Three-dimensional model of Fluo3 binding a Ca2+ ion (purple). The structures show
the participation of the two nitrogens (blue) and six oxygens (red) that bind to Ca2+,
causing Ca2+ to be enveloped by the chelator.

In the chimeric molecules, the fluorophore can be quenched by electrons in lone pairs on the BAPTA moiety. But when a positively charged Ca2+ ion is present, it forms bonds with those electrons, lowering their energy and making it energetically unfavorable for them to fill the vacancy left by the excited electron. Without competition for the vacated orbital, the excited electron can relax back into it, emitting a photon.

“Calcium allows it to fluoresce beautifully,” Minta said. In a test tube, fluo-3’s brightness increased by 40- to 100-fold when calcium was added.

In a second paper in the same issue of JBC, Kao and several colleagues tested the probes for live-cell imaging. They found that cells took up the indicators through incubation with the corresponding acetoxymethyl esters and confirmed a dazzling increase in fluorescence when they applied Ca2+-mobilizing agonists.

Fluo-3 quickly was adopted for many uses. By 1995, researchers had reported watching waves of Ca2+ activity pass through connected networks of neurons in mouse brain slices, observing cell-cycle initiation in fertilized egg cells, and detecting “Ca2+ sparks” — microscopic, elementary Ca2+ signals generated by the coordinated opening of small clusters of Ca2+-release channels — on the sarcoplasmic reticulum in heart cells. Kao said the new technologies “made calcium measurement accessible to essentially anyone with a microscope.”

Tsien was disappointed, however, that the new probes changed only in intensity, not in excitation or emission wavelength, upon Ca2+ binding; he had hoped to be able to do ratiometric imaging.

“Roger was almost always dissatisfied with any product that you made,” Kao said. “He had a perfect conception of how they should behave, and then they would fall short on one or another aspect, and he’d be a little rueful: ‘If only we had discovered how to do this.’”

Tsien finally got his visible ratiometric Ca2+ sensor about 10 years later. It was based on GFP and the calcium-binding protein calmodulin; though calcium could not be cloned, cloning turned out to be useful in its study after all.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition weekly.

Learn more
Laurel Oldach

Laurel Oldach is a former science writer for the ASBMB.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

CRISPR gene editing: Moving closer to home
News

CRISPR gene editing: Moving closer to home

Nov. 17, 2024

With the first medical therapy approved, there’s a lot going on in the genome editing field, including the discovery of CRISPR-like DNA-snippers called Fanzors in an odd menagerie of eukaryotic critters.

Finding a missing piece for neurodegenerative disease research
News

Finding a missing piece for neurodegenerative disease research

Nov. 16, 2024

Ursula Jakob and a team at the University of Michigan have found that the molecule polyphosphate could be what scientists call the “mystery density” inside fibrils associated with Alzheimer’s, Parkinson’s and related conditions.

From the journals: JLR
Journal News

From the journals: JLR

Nov. 15, 2024

Enzymes as a therapeutic target for liver disease. Role of AMPK in chronic liver disease Zebrafish as a model for retinal dysfunction. Read about the recent JLR papers on these topics.

Computational and biophysical approaches to disordered proteins
Award

Computational and biophysical approaches to disordered proteins

Nov. 14, 2024

Rohit Pappu will receive the 2025 DeLano Award for Computational Biosciences at the ASBMB Annual Meeting, April 12-15 in Chicago.

From lab to land: Crop modifications are fortifying our food supply against climate change
News

From lab to land: Crop modifications are fortifying our food supply against climate change

Nov. 13, 2024

Scientists explore genetic and biochemical innovations fueling future-proofing agriculture

Join the pioneers of ferroptosis at cell death conference
In-person Conference

Join the pioneers of ferroptosis at cell death conference

Nov. 13, 2024

Meet Brent Stockwell, Xuejun Jiang and Jin Ye — the co-chairs of the ASBMB’s 2025 meeting on metabolic cross talk and biochemical homeostasis research.